IHT Wealth Management’s Regenxbio RGNX Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q4 | – | Sell |
-9,937
| Closed | -$263K | – | 930 |
|
|
2022
Q3 | $263K | Sell |
9,937
-8,120
| -45% | -$215K | 0.02% | 669 |
|
|
2022
Q2 | $446K | Hold |
18,057
| – | – | 0.04% | 413 |
|
|
2022
Q1 | $599K | Sell |
18,057
-1,010
| -5% | -$33.5K | 0.05% | 373 |
|
|
2021
Q4 | $623K | Buy |
19,067
+9,800
| +106% | +$320K | 0.05% | 374 |
|
|
2021
Q3 | $388K | Sell |
9,267
-6
| -0.1% | -$251 | 0.03% | 511 |
|
|
2021
Q2 | $360K | Sell |
9,273
-1,069
| -10% | -$41.5K | 0.02% | 641 |
|
|
2021
Q1 | $353K | Sell |
10,342
-2,100
| -17% | -$71.7K | 0.03% | 572 |
|
|
2020
Q4 | $564K | Sell |
12,442
-1,370
| -10% | -$62.1K | 0.05% | 367 |
|
|
2020
Q3 | $380K | Buy |
13,812
+2,620
| +23% | +$72.1K | 0.04% | 414 |
|
|
2020
Q2 | $412K | Buy |
11,192
+50
| +0.4% | +$1.84K | 0.06% | 327 |
|
|
2020
Q1 | $361K | Sell |
11,142
-290
| -3% | -$9.4K | 0.05% | 338 |
|
|
2019
Q4 | $468K | Buy |
11,432
+1,070
| +10% | +$43.8K | 0.06% | 342 |
|
|
2019
Q3 | $369K | Buy |
10,362
+2,770
| +36% | +$98.6K | 0.05% | 377 |
|
|
2019
Q2 | $390K | Buy |
7,592
+2,100
| +38% | +$108K | 0.06% | 343 |
|
|
2019
Q1 | $315K | Buy |
5,492
+432
| +9% | +$24.8K | 0.05% | 351 |
|
|
2018
Q4 | $212K | Buy |
5,060
+1,420
| +39% | +$59.5K | 0.04% | 412 |
|
|
2018
Q3 | $275K | Buy |
3,640
+370
| +11% | +$28K | 0.06% | 345 |
|
|
2018
Q2 | $235K | Buy |
+3,270
| New | +$235K | 0.06% | 349 |
|